Kare Schultz earned $107m during Teva tenure Finances April 20, 2023 [ad_1] Former Teva Pharmaceutical Industries Ltd. (NYSE: TEVA; TASE: TEVA) CEO Kåre Schultz earned $107 million throughout his time…
